Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02868970Phase 4Completed
Phase 4, open-label trial (2 arms), sponsored by Canadian Immunization Research Network. Primary endpoint: Number of Vaccines Administered by Participating Pharmacies at 2 years. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02868970.